Yang Hongyi, Li Gang, Jin Haixia, Guo Yihong, Sun Yingpu
Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University Reproductive Medical Center, Zhengzhou 450052, China.
Transl Androl Urol. 2019 Aug;8(4):356-365. doi: 10.21037/tau.2019.06.22.
The sperm DNA fragmentation index (DFI) is widely regarded as a key measure for assessing male fertility, but the predictive value of the DFI for outcomes of assisted reproductive technology (ART) remains under debate. In this study, we used a large sample to analyze the effect of sperm DFI on pregnancy outcomes following ART and its relationship with oocyte fertilization and embryo development in in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI). We also explore the value of sperm DNA fragmentation (SDF) and its associated factors in assessing male fertility.
The relationship between the DFI measured with the sperm chromatin structure assay (SCSA) and pregnancy outcomes following ART were retrospectively analyzed in 2,622 ART treatment cycles, of which 1,185 were intrauterine insemination (IUI) cycles, 1,221 were IVF cycles and 216 were ICSI cycles. Rates of pregnancy, early abortion, oocyte fertilization and good quality embryos from IVF and ICSI cycles were compared between the groups of low DFI (DFI ≤15%), medium DFI (15%< DFI <30%) and high DFI (DFI ≥30%). Additionally, the relationships between sperm DFI and male lifestyle variables such as age, body mass index, smoking, and alcohol consumption, as well as routine semen parameters, were analyzed.
Clinical pregnancy rates following IUI among high, medium, and low sperm DFI groups were 12.5% (11/88), 14.3% (48/336), and 13.4% (102/761), respectively, with no statistical difference between the groups (P=0.88); however, early abortion rates among these groups were 27.3% (3/11), 14.6% (7/48), and 4.9% (5/102), respectively, and the difference was statistically significant (P=0.02). No significant differences in the rates of clinical pregnancy, early abortion, oocyte fertilization, or good quality embryos in IVF or ICSI cycles were detected among different DFI groups (P<0.05). Sperm DFI was negatively associated with sperm density, vitality and normal morphology; It was positively correlated with age, abstinence time and unhealthy lifestyles.
As an increasingly common technique for reproductive testing, sperm DFI has proven to be very valuable in male fertility evaluation, but its significance as a predictor of pregnancy outcomes following ART requires further investigation.
精子DNA碎片化指数(DFI)被广泛认为是评估男性生育能力的关键指标,但DFI对辅助生殖技术(ART)结局的预测价值仍存在争议。在本研究中,我们使用大样本分析了精子DFI对ART后妊娠结局的影响及其与体外受精(IVF)/卵胞浆内单精子注射(ICSI)中卵母细胞受精和胚胎发育的关系。我们还探讨了精子DNA碎片化(SDF)及其相关因素在评估男性生育能力中的价值。
回顾性分析了2622个ART治疗周期中,采用精子染色质结构分析(SCSA)测量的DFI与ART后妊娠结局之间的关系,其中1185个是宫腔内人工授精(IUI)周期,1221个是IVF周期,216个是ICSI周期。比较了低DFI组(DFI≤15%)、中DFI组(15%<DFI<30%)和高DFI组(DFI≥30%)在IVF和ICSI周期中的妊娠率、早期流产率、卵母细胞受精率和优质胚胎率。此外,还分析了精子DFI与男性生活方式变量(如年龄、体重指数、吸烟和饮酒)以及常规精液参数之间的关系。
高、中、低精子DFI组IUI后的临床妊娠率分别为12.5%(11/88)、14.3%(48/336)和13.4%(102/761),组间差异无统计学意义(P=0.88);然而,这些组的早期流产率分别为27.3%(3/11)、14.6%(7/48)和4.9%(5/102),差异有统计学意义(P=0.02)。在不同DFI组的IVF或ICSI周期中,临床妊娠率、早期流产率、卵母细胞受精率或优质胚胎率均未检测到显著差异(P<0.05)。精子DFI与精子密度、活力和正常形态呈负相关;与年龄、禁欲时间和不健康生活方式呈正相关。
作为一种越来越常见的生殖检测技术,精子DFI已被证明在男性生育能力评估中非常有价值,但其作为ART后妊娠结局预测指标的意义仍需进一步研究。